Skip to content

Instantly share code, notes, and snippets.

View HML-150's full-sized avatar

HML-150

  • Joined Aug 30, 2025
View GitHub Profile
@HML-150
HML-150 / S1: Study characteristics table.xml
Last active August 31, 2025 05:07
this space provides both S1 and S2
Title Citation Sample size Participant ratio Patient characteristics Treatment vs Control Course of treatment Control measures Outcome With adverse effect mentioned?
Experimental Control Age Gender (F:M) Course of disease (duration/severity) Disease type Duration Measures (main acupoints)
中医针灸治疗慢性溃疡性结肠炎的疗效观察 Yan et al., 2020 150 75 MA 75 WD Exp 24–76, C 25–75 Exp 35:40, C 30:45 Exp 9m–17m, C 9m–18m Chronic UC MA vs Metronidazole + Sulfasalazine 1 session/d, 30 min/session Acupuncture: ST25, CV4, CV6, BL25 Metronidazole 0.2 g ×3/d + Sulfasalazine 2 g ×3/d therapeutic effect grading N
中医针灸治疗慢性溃疡性结肠炎疗效探讨 Lu et al., 2021 94 47 MA 47 WD Exp 21–70 (mean 42.4±8.3), C 22–71 (mean 43.5±7.9) Exp 23:24, C 22:25 Exp 9 m–16 y (mean 5.8±2.9 y), C 11 m–18 y (mean 6.4±3.2 y) Chronic UC MA vs Metronidazole + Sulfasalazine 1 session/d, 15 min/session, 1 w = 1 course, 2 courses total Acupuncture: CV6,CV4, BL25, GV1, SP6, ST36 Metronidazole 0.2 g ×3/d + Sulfasalazine 0.2 g ×3/d, 2 w/course therapeutic effect grading,